GLP-1 Medications for Weight Loss: What to Expect in the First 90 Days
GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have reshaped the conversation around medical weight management. For many patients, these medications produce meaningful weight loss that diet and exercise alone couldn’t achieve. But starting GLP-1 therapy comes with a learning curve, and understanding what to expect during the first 90 days helps patients stay the course and optimize their results.
Weeks 1–4: The Adjustment Phase
Most GLP-1 medications are initiated at a low dose and titrated upward over weeks or months to minimize gastrointestinal side effects. During the first few weeks, patients commonly experience nausea, reduced appetite, and in some cases mild fatigue or constipation. These effects are most pronounced with dose increases and typically diminish as the body adjusts.
Actual weight loss in the first month is often modest — typically 2–5 pounds — and patients who expect dramatic early results can become discouraged. What’s actually happening during this phase is the medication is establishing its effect on appetite signaling and gastric motility, laying the foundation for more meaningful results later.
Practical strategies that help during this phase: eating smaller portions more slowly, avoiding high-fat or high-sugar foods that worsen nausea, staying well hydrated, and taking the injection on a day when you can rest if side effects are more pronounced.
Weeks 4–8: Appetite Reduction Becomes Noticeable
By the second month, most patients on therapeutic or near-therapeutic doses begin to experience meaningful appetite reduction. Many describe a “food noise” reduction — the persistent, intrusive thoughts about eating that drive overeating become quieter or disappear entirely. Satiety arrives faster during meals and lasts longer.
Weight loss accelerates during this phase for most patients, averaging 1–2 pounds per week. The medication is doing its primary job: reducing caloric intake without requiring constant conscious effort or willpower. Patients who also implement structured nutrition and movement habits during this window tend to see compounding benefits.
Weeks 8–12: Establishing the Pattern
By the third month, the medication’s effects are typically well established, side effects have diminished for most patients, and the weekly rhythm of the injection is routine. Total weight loss of 10–20+ pounds in 90 days is achievable for many patients, though results vary significantly based on starting weight, dose reached, diet quality, and individual metabolic response.
This is also the phase where metabolic markers often begin improving — blood pressure, fasting glucose, and lipid profiles frequently show meaningful improvement even before major weight loss milestones are reached.
TeleZen MD offers physician-supervised GLP-1 weight loss programs delivered via telemedicine, making medically guided care accessible without the barriers of traditional clinic visits.
If you’re considering GLP-1 therapy, consult with a licensed provider at TeleZen MD to find the right protocol and ensure you’re supported throughout the process.
